GR3015431T3 - Use of acetyl L-carnitine in the therapeutic treatment of coma. - Google Patents
Use of acetyl L-carnitine in the therapeutic treatment of coma.Info
- Publication number
- GR3015431T3 GR3015431T3 GR940403979T GR940403979T GR3015431T3 GR 3015431 T3 GR3015431 T3 GR 3015431T3 GR 940403979 T GR940403979 T GR 940403979T GR 940403979 T GR940403979 T GR 940403979T GR 3015431 T3 GR3015431 T3 GR 3015431T3
- Authority
- GR
- Greece
- Prior art keywords
- carnitine
- acetyl
- coma
- therapeutic treatment
- acceptable salts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM910002A IT1244636B (it) | 1991-01-04 | 1991-01-04 | Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento. |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3015431T3 true GR3015431T3 (en) | 1995-06-30 |
Family
ID=11399703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR940403979T GR3015431T3 (en) | 1991-01-04 | 1995-03-16 | Use of acetyl L-carnitine in the therapeutic treatment of coma. |
Country Status (12)
Country | Link |
---|---|
US (1) | US5192805A (el) |
EP (1) | EP0498144B1 (el) |
JP (1) | JP3145451B2 (el) |
AT (1) | ATE119770T1 (el) |
DE (1) | DE69201660T2 (el) |
DK (1) | DK0498144T3 (el) |
ES (1) | ES2070478T3 (el) |
GR (1) | GR3015431T3 (el) |
HK (1) | HK1005847A1 (el) |
IE (1) | IE66025B1 (el) |
IT (1) | IT1244636B (el) |
ZA (1) | ZA9110037B (el) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1254314B (it) * | 1992-03-27 | 1995-09-14 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari. |
IT1263004B (it) * | 1992-10-08 | 1996-07-23 | Sigma Tau Ind Farmaceuti | Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti. |
IT1277898B1 (it) * | 1995-08-03 | 1997-11-12 | Mendes Srl | Uso di amminoacidi basici, di acil derivati di amminoacidi basici e di loro sali farmaceuticamente accettabili per la profilassi di malattie |
IT1276225B1 (it) * | 1995-10-17 | 1997-10-27 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per |
IT1276253B1 (it) | 1995-12-15 | 1997-10-27 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi |
US5872008A (en) * | 1996-02-09 | 1999-02-16 | Bair; Glenn O. | Methods for diagnosing pre-menstrual syndrome |
IT1283951B1 (it) * | 1996-03-15 | 1998-05-07 | Mendes Srl | Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di |
IT1291113B1 (it) * | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizione nutritiva terapeutica per soggetti affetti da diabete mellito |
US6090848A (en) * | 1997-12-01 | 2000-07-18 | Sigma-Tau Healthscience S.P.A. | Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans |
US5863940A (en) | 1997-12-01 | 1999-01-26 | Sigma-Tau Healthscience S.P.A. | Medicament and therapeutical method for treating idiopathic asthenozoospermia |
PT951909E (pt) | 1998-03-19 | 2004-04-30 | Sigma Tau Ind Farmaceuti | Composicao combinada que contem uma l-carnitina ou uma alcanoil-l-carnitina um glicosaminoglicano e/ou um seu constituinte |
US8173618B2 (en) * | 2003-07-25 | 2012-05-08 | University Of Massachusetts | Formulations for reducing neuronal degeneration |
US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
US8597640B2 (en) * | 2007-10-31 | 2013-12-03 | University Of Massachusetts Lowell | Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging |
SG185692A1 (en) * | 2010-06-16 | 2013-01-30 | Sigma Tau Ind Farmaceuti | Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue |
EP2586438A1 (en) | 2011-10-28 | 2013-05-01 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Compound useful for preventing cognitive deficit disorders in a new born from HIV-seropositive pregnant female who is in treatment with azidothymidine |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4346107A (en) * | 1979-02-12 | 1982-08-24 | Claudio Cavazza | Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism |
IT1150396B (it) * | 1982-12-09 | 1986-12-10 | Sigma Tau Ind Farmaceuti | Impiego di alcanoil l-carnitine per il trattamento terapeutico di miopa tie e distrofie muscolari |
IT1184655B (it) * | 1985-10-14 | 1987-10-28 | Sigma Tau Ind Farmaceuti | Imiego di acetil l-carnitina nel trattamento terapeutico degli stati di shock |
IT1196564B (it) * | 1986-08-04 | 1988-11-16 | Sigma Tau Ind Farmaceuti | Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche |
IT1240760B (it) * | 1990-02-12 | 1993-12-17 | Sigma Tau Ind Farmaceuti | Esteri di acil-l-carnitine con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che li contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma. |
-
1991
- 1991-01-04 IT ITRM910002A patent/IT1244636B/it active IP Right Grant
- 1991-12-20 ZA ZA9110037A patent/ZA9110037B/xx unknown
- 1991-12-27 JP JP34691591A patent/JP3145451B2/ja not_active Expired - Fee Related
- 1991-12-30 IE IE456891A patent/IE66025B1/en not_active IP Right Cessation
-
1992
- 1992-01-01 DE DE69201660T patent/DE69201660T2/de not_active Expired - Fee Related
- 1992-01-01 ES ES91830583T patent/ES2070478T3/es not_active Expired - Lifetime
- 1992-01-01 EP EP91830583A patent/EP0498144B1/en not_active Expired - Lifetime
- 1992-01-01 AT AT91830583T patent/ATE119770T1/de not_active IP Right Cessation
- 1992-01-01 DK DK91830583.0T patent/DK0498144T3/da active
- 1992-01-03 US US07/816,224 patent/US5192805A/en not_active Expired - Lifetime
-
1995
- 1995-03-16 GR GR940403979T patent/GR3015431T3/el unknown
-
1998
- 1998-06-05 HK HK98104930A patent/HK1005847A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2070478T3 (es) | 1995-06-01 |
EP0498144B1 (en) | 1995-03-15 |
DK0498144T3 (da) | 1995-07-24 |
ITRM910002A0 (it) | 1991-01-04 |
JP3145451B2 (ja) | 2001-03-12 |
HK1005847A1 (en) | 1999-01-29 |
IE66025B1 (en) | 1996-01-10 |
US5192805A (en) | 1993-03-09 |
JPH04295424A (ja) | 1992-10-20 |
IT1244636B (it) | 1994-08-08 |
DE69201660D1 (de) | 1995-04-20 |
DE69201660T2 (de) | 1995-07-20 |
IE914568A1 (en) | 1992-07-15 |
EP0498144A1 (en) | 1992-08-12 |
ATE119770T1 (de) | 1995-04-15 |
ITRM910002A1 (it) | 1992-07-04 |
ZA9110037B (en) | 1992-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1005847A1 (en) | Use of acetyl l-carnitine in the therapeutic treatment of coma | |
EP0513702A3 (en) | Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication | |
EP0256999A3 (en) | Use of acetyl l-carnitine in the therapeutical treatment of peripheral neuropathies | |
ZA926241B (en) | Dosage form for delivering drug in short-time period | |
EP0612248A4 (en) | Combination chemotherapy. | |
IL103303A (en) | Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain | |
EP0217206A3 (en) | Medicament against chronic graft-versus-host diseases, as well as against autoimmune diseases, particularly systemic lupus erythematodes | |
AU4658489A (en) | Use of acetyl d-carnitine in the therapeutic treatment of glaucoma | |
AU1117092A (en) | Treatment of lower urinary tract disorders | |
ZA898667B (en) | Use of acetyl l-carnitine in the therapeutic treatment of cataract and pharmaceutical compositions useful in such treatment | |
RU94002133A (ru) | 6-хлор-5-фтор-3-(2-теноил)-2-оксиндол-1-карбоксамид как аналгезирующее и противовоспалительное средство | |
EP0207011A3 (en) | Use of some alkanoyl l-carnitines for the therapeutical treatment of idiopathic and induced parkinsonism | |
IT1224250B (it) | Associzione del depiprazolo con la morfina | |
GB2208798B (en) | Anti-cancer agent comprising l-ascorbic acid and o-benzylidene-l-ascorbic acid or deuterated derivative | |
ZA945431B (en) | Use of benzydamine in the treatment of pathological conditions caused by TNF | |
IT1216096B (it) | L_piroglutamil_l_cisteina, dipeptide ad elevata attivita'anticatarattogena e composizioni farmaceutiche che lo contengono. | |
KR930019207A (ko) | 카르니틴 결핍 hiv-혈청양성 환자 치료용 l-카르니틴의 용도 | |
OA09790A (en) | "Paromomycin or its derivatives or salts thereof for parenteral treatment of human parasitic diseases". | |
MX9707735A (es) | Nuevo uso de (s)-adenosil-l-metionina (same). | |
EP0253777A3 (en) | Use of l-carnitine in the treatment of toxic effects induced by the inhalation of halotane and other halogen-containing general anesthetics | |
MX9701294A (es) | Un medicamento que contiene un derivado de carnitina para el tratamiento de la arterioesclerosis cronica obliteradora. | |
RU95122486A (ru) | Средство для лечения тикозных гиперкинезов | |
TW360538B (en) | Pharmaceutical composition containing 4'-iodo-4'-deoxydoxorubicin for treatment of amyloidosis | |
ITTO910183A0 (it) | Urologica farmaco terapia |